ArticleOncotarget2017

Dysregulated connexin 43 in HER2-positive drug resistant breast cancer cells enhances proliferation and migration.

Elizabeth S Yeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.